These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 688)

  • 41. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
    Lee RJ; Evans DB; Baky SH; Laffan RJ
    Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Negative inotropic reflex effects in the dog ventricle before and after beta-receptor blockade].
    Scheufler K; Opitz H
    Biomed Biochim Acta; 1986; 45(5):637-47. PubMed ID: 2875715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proceedings: Combined effects of Lb46 resp. practolol and histamine on parameters of respiration and circulation in guinea pigs.
    Kilian U; Dittmann EC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R47. PubMed ID: 4152364
    [No Abstract]   [Full Text] [Related]  

  • 44. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Celiprolol--pharmacological profile of an unconventional beta-blocker.
    Wolf PS; Smith RD; Khandwala A; Van Inwegen RG; Gordon RJ; Mann WS; Romano DV; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 40():5-11. PubMed ID: 2864065
    [No Abstract]   [Full Text] [Related]  

  • 46. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol.
    Carissimi M; Gentili P; Grumelli E; Milla E; Picciola G; Ravenna F
    Arzneimittelforschung; 1976 Apr; 26(4):506-16. PubMed ID: 8056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
    Cheymol G; Mouillé P; Schmitt H; Laubie M
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):45-51. PubMed ID: 4148408
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of cordanum and propranolol on coronary resistance].
    Tverskaia MS; Kositskiĭ GI
    Biull Eksp Biol Med; 1988 Jun; 105(6):690-2. PubMed ID: 2898952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of effects of beta-blocking drugs on blood glucose levels and insulin hypoglycaemia in rats.
    Baird JR; Carter AJ
    Eur J Pharmacol; 1974 Feb; 25(2):275-8. PubMed ID: 4154855
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative effects of several beta-adrenergic inhibitors on pulmonary resistance in guinea pigs].
    Giudicelli JF; Boissier JR; Dumas Y; Advenier C
    C R Seances Soc Biol Fil; 1973; 167(2):232-7. PubMed ID: 4153959
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 55. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium.
    Buck JD; Gross GJ; Warltier DC; Jolly SR; Hardman HF
    Am J Cardiol; 1979 Oct; 44(4):657-63. PubMed ID: 39449
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1971 Sep; 43(1):222-35. PubMed ID: 4400184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Nakao K; Takagi K
    Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.
    Saunders J; Gomeni R; Kilborn JR; Morselli PL; Sönksen PH
    Eur J Clin Pharmacol; 1981; 21(3):177-84. PubMed ID: 6119203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative potency of intravenous penbutolol and propranolol in man.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.